
DED cream – trial begins
Glaukos has enrolled its first patient for its phase 2 trials of GLK-301, a pilocarpine-based cream applied to the outer eyelid to treat dry eye disease (DED). The California-based ophthalmic
4295 articles

Glaukos has enrolled its first patient for its phase 2 trials of GLK-301, a pilocarpine-based cream applied to the outer eyelid to treat dry eye disease (DED). The California-based ophthalmic

US researchers have reported four cases or corneal transplant rejection in patients following their Covid-19 vaccinations.

A US study of diabetic children, published in Jama Ophthalmology, has found that those with type-2 diabetes (T2D) had nearly double the risk of developing retinopathy compared to those with type-1 (T1D). Further, authors noted pars plana vitrectomy occurred within a shorter diabetes duration for T2D

Independent optometrist Ocula has acquired Christchurch’s iconic Groovy Glasses, taking the network to four practices across the Garden City and Queenstown Lakes District.

An Australian-developed bionic eye for retinitis pigmentosa (RP) patients has been granted ‘breakthrough’ designation by the US Food and Drug Administration (FDA), fast tracking its review process.

Lumenis is hosting a Dry Eye Summit live at the Sydney Hilton Hotel, providing an opportunity for educational discussion, collaboration and networking. The event will feature presentations from three

A new UK optometry apprenticeship pathway, submitted to the Institute for Apprenticeships and Technical Education (IFATE) led by the country’s larger optometry employers, is being reconsidered in the face of strong opposition from the UK’s Association of Optometrists (AOP).

The ZEISS CLARUS 700 is the first fundus camera to combine an ultra-widefield of view with True colour high-resolution imaging. And now it comes with a full suite of imaging capabilities – including fluorescein angiography – and advanced features to collect the best image, every time.

A Turkish study has shown that some patients had significant alterations in corneal and lenticular densitometric values following Covid-19 infection.

Glaucoma New Zealand (GNZ) is launching a new online education programme for optometrists, developed by University of Auckland Professor Helen Danesh-Meyer, a founding trustee of GNZ, and Dr Hannah Kersten.

Despite being planned as a hybrid event, the annual Cornea and Contact Lens Society (CCLS) conference planned for 10-12 March 2022 has been postponed due to modelling of the Covid-19 Omicron variant suggesting a peak in March.

Rodenstock’s new Bold concept places a special focus on technical details and innovative technologies. Made from Italian acetate and Japanese titanium, the R8030 offers contrast both in materials and